← Back to Search

Fitbit for Degenerative Spinal Stenosis

N/A
Waitlist Available
Research Sponsored by The London Spine Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up number consented by 17 months
Awards & highlights
No Placebo-Only Group

Summary

This trial uses Fitbit devices to monitor and motivate patients who have had spinal surgery to walk more. It aims to see if this can help them recover better and become more active.

Eligible Conditions
  • Degenerative Spinal Stenosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~number consented by 17 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and number consented by 17 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Self-Paced Walking Test
Secondary study objectives
Back Pain
Functional Ability
General Health
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: FitbitExperimental Treatment1 Intervention
Fitbit plus step goal and activity feedback
Group II: Blinded FitbitExperimental Treatment1 Intervention
Blinded Fitbit, no step goal, and no activity feedback
Group III: ControlActive Control1 Intervention
Standard of care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Blinded Fitbit
2016
N/A
~140
Fitbit
2021
N/A
~3560

Find a Location

Who is running the clinical trial?

The London Spine CentreLead Sponsor
5 Previous Clinical Trials
1,108 Total Patients Enrolled
~8 spots leftby Dec 2025